120 Participants Needed

SHARE Program for Alzheimer's Disease

(SHARE Trial)

SO
ZF
Overseen ByZoe Fete
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Benjamin Rose Institute on Aging
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to adapt and test a care planning program specifically for African-Americans dealing with early to moderate dementia, such as Alzheimer's. The study will compare a new, culturally tailored intervention involving counseling sessions and printed resources to the usual care, which consists of a single educational session. It seeks African-American individuals with mild to moderate dementia who live at home and experience memory loss symptoms, along with their caregivers. Participants should be able to speak and read English and feel comfortable managing early dementia symptoms.

As an unphased trial, this study offers a unique opportunity to contribute to research that could improve culturally sensitive care for dementia.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this adapted SHARE program is safe for African-Americans with early-moderate stage dementia and their care partners?

Studies have shown that the SHARE program, designed to assist people with dementia and their caregivers in planning future care, is generally well-received. Research involving 40 caregiver and patient pairs found that structured conversations about future care were acceptable, suggesting the program is safe to use. The program includes counseling sessions and resources, making it a low-risk option. No significant negative effects have been reported from these sessions. Participants find the sessions helpful and manageable.12345

Why are researchers excited about this trial?

Researchers are excited about the SHARE Program for Alzheimer's Disease because it offers a fresh approach to dyadic care planning, focusing on both people living with dementia (PLWD) and their caregivers (CGs) together. Unlike standard treatments that mostly concentrate on medication management, the SHARE intervention provides a series of personalized sessions over 8-10 weeks that are culturally adapted and curriculum-guided. This method not only aims to improve communication and planning between PLWDs and CGs but also emphasizes emotional support and practical strategies. By involving both parties in the care process, the program has the potential to significantly enhance their quality of life and care experience, which is a promising step forward in Alzheimer's management.

What evidence suggests that this trial's treatments could be effective for Alzheimer's disease?

Research has shown that programs like the SHARE Dyadic Intervention, which participants in this trial may receive, involve both individuals with early to moderate dementia and their caregivers and can be helpful. A review of several studies found that these programs can improve communication and planning for future care. By focusing on joint decision-making and providing guidance, participants often feel more prepared and supported. Those who have participated in these programs reported feeling better emotionally and having a clearer understanding of their care options. This approach helps both the person with dementia and their caregiver manage the challenges of the condition together.26789

Who Is on the Research Team?

SO

Silvia Orsulic-Jeras

Principal Investigator

Benjamin Rose Institute on Aging

Are You a Good Fit for This Trial?

This trial is for African-American families where one member has early to moderate-stage dementia, likely Alzheimer's disease. The focus is on the patient-caregiver pair, known as a dyad. Specific eligibility criteria are not provided.

Inclusion Criteria

Care-recipient lives at home
The caregiver (CG) and/or the person with dementia (PWD), or symptoms of memory loss must identify as African American
Ability to speak and read English
See 3 more

Exclusion Criteria

Intellectual or developmental disability
A traumatic brain injury
Individuals experiencing extreme difficulty adjusting and coping to the diagnosis
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the culturally adapted SHARE intervention consisting of up to five, 60-90 minute sessions over an 8-10 week period

8-10 weeks
5 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

2-4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • 5+1 Adapted, early-stage dyadic care planning intervention
  • Counseling session and printed resources
Trial Overview The study tests an adapted version of the SHARE program, designed specifically for African-Americans. It includes counseling and resources aimed at care planning. Participants will be randomly assigned to either this new program or usual care.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment (SHARE Dyadic Intervention)Experimental Treatment1 Intervention
Group II: Control (Treatment as usual single session)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Benjamin Rose Institute on Aging

Lead Sponsor

Trials
5
Recruited
2,600+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Citations

A dyadic advance care planning intervention for people ...Advance care planning (ACP) is highly relevant for people with early-stage dementia to communicate their care preferences for serious ...
A dyadic advance care planning intervention for people with ...Advance care planning (ACP) is highly relevant for people with early-stage dementia to communicate their care preferences for serious ...
A dyadic perspective on assessment in Alzheimer's dementia ...A comprehensive overview of available valid and reliable psychosocial measures that assess a selection of important domains for dementia care planning.
Dyadic interventions for community-dwelling people with ...In this review, we study the effects of dyadic psychosocial interventions focused on community-dwelling people with dementia and their family caregivers, and ...
The effectiveness of dyadic interventions for people with ...The twelve studies identified used a variety of intervention approaches including support group, counseling, cognitive stimulation, skill ...
A dyadic perspective on assessment in Alzheimer's dementiaThis article will focus on concepts that are strength‐based and most relevant to care dyads as they navigate the difficult disease trajectory.
Implementation of an early-stage dyadic care-planning ...This article describes the implementation of SHARE (Support, Health, Activities, Resources, and Education), a counseling-based care-planning ...
A dyadic perspective on assessment in Alzheimer's dementia ...This article will focus on concepts that are strength‐based and most relevant to care dyads as they navigate the difficult disease trajectory.
9.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/27738110/
Implementation of an early-stage dyadic care-planning ...Data were collected from 40 early-stage dementia care dyads to determine the acceptability of having structured discussions about future care in the early ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security